Adult bradycardia (peri-arrest, ALS)
Peri-arrest bradycardia · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Symptomatic bradycardia managed on the Resuscitation Council UK adult bradycardia algorithm. Adverse features drive escalation from atropine to pacing; identify those at risk of asystole.
Assessment
Investigations
- ECG/monitor; identify adverse features (shock, syncope, myocardial ischaemia, heart failure)
- Identify asystole risk (recent asystole, Mobitz II, complete heart block with broad QRS, ventricular pauses >3 s)
- Electrolytes, drugs (beta-blocker/CCB/digoxin), ischaemia
Management
- Adverse features or asystole risk: atropine 500 micrograms IV, repeat every 3-5 min to a maximum of 3 mg
- If no response: transcutaneous pacing, OR isoprenaline/adrenaline (2-10 micrograms/min) infusion while preparing pacing
- Seek expert help; arrange transvenous pacing
- Treat reversible causes (drug toxicity, electrolytes, ischaemia)
- No adverse features and no asystole risk: observe and monitor
Drugs & doses
Atropine 500 micrograms IV (max 3 mg)
Transcutaneous pacing
Isoprenaline / adrenaline infusion
Transvenous pacing
Disposition
Monitored bed / cardiology.
In peri-arrest bradycardia, atropine to a maximum of 3 mg then pace - and remember Mobitz II and complete heart block carry a high asystole risk.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.